| 97.2 -0.03 (-0.03%) | 09-03 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 117.55 | 1-year : | 123.53 |
| Resists | First : | 100.64 | Second : | 105.76 |
| Pivot price | 94.64  |
|||
| Supports | First : | 92.36 | Second : | 76.84 |
| MAs | MA(5) : | 95.79 |
MA(20) : | 94.71 |
| MA(100) : | 95.08 |
MA(250) : | 83.51 |
|
| MACD | MACD : | -1.3 |
Signal : | -2 |
| %K %D | K(14,3) : | 85.9 |
D(3) : | 67.8 |
| RSI | RSI(14): 51.1  |
|||
| 52-week | High : | 110 | Low : | 67.45 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ CVS ] has closed below upper band by 12.3%. Bollinger Bands are 43% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 7 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 98.17 - 98.71 | 98.71 - 99.15 |
| Low: | 94.37 - 95.04 | 95.04 - 95.59 |
| Close: | 96.17 - 97.2 | 97.2 - 98.06 |
CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.
Fri, 04 Sep 2026
Is CVS Health Outperforming the Nasdaq? - Barchart.com
Fri, 04 Sep 2026
TD Waterhouse Canada Inc. Increases Stake in CVS Health Corporation $CVS - MarketBeat
Thu, 03 Sep 2026
Updated COVID-19 vaccines available at CVS Pharmacy and MinuteClinic across the U.S. - CVS Health
Thu, 03 Sep 2026
Most insured patients can get updated COVID vaccines at CVS for no cost - stocktitan.net
Thu, 03 Sep 2026
Nykredit A S Purchases New Position in CVS Health Corporation $CVS - MarketBeat
Wed, 02 Sep 2026
Did CVS Health Corporation Insiders Breach their Fiduciary Duties to Shareholders? - Morningstar
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NYSE
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Healthcare Plans
|
|
| Shares Out | 1,280 (M) |
| Shares Float | 1,280 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 90.8 (%) |
| Shares Short | 18,680 (K) |
| Shares Short P.Month | 19,940 (K) |
| EPS | 3.78 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 62.36 |
| Profit Margin | 1.1 % |
| Operating Margin | 3.8 % |
| Return on Assets (ttm) | 2.9 % |
| Return on Equity (ttm) | 6.1 % |
| Qtrly Rev. Growth | 7 % |
| Gross Profit (p.s.) | 43.99 |
| Sales Per Share | 322.37 |
| EBITDA (p.s.) | 13.03 |
| Qtrly Earnings Growth | 188.8 % |
| Operating Cash Flow | 14,780 (M) |
| Levered Free Cash Flow | 8,080 (M) |
| PE Ratio | 25.64 |
| PEG Ratio | 0.2 |
| Price to Book value | 1.55 |
| Price to Sales | 0.3 |
| Price to Cash Flow | 8.41 |
| Dividend | 0.67 |
| Forward Dividend | 0 |
| Dividend Yield | 0.6% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|